v3.26.3
Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Mar. 31, 2025   695,938,323        
Beginning balance at Mar. 31, 2025 $ 5,187,198 $ 0 $ 4,562,107 $ 9,438 $ 116,060 $ 499,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   6,560,959        
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments 16,912   16,912      
Exercise and vesting of subsidiary share awards 3,613   2,325     1,288
Repurchase of the Company's common shares (in shares)   (20,269,450)        
Repurchase of the Company’s common shares (208,293)       (208,293)  
Share-based compensation 82,178   63,031     19,147
Unrealized (losses) gains on available-for-sale securities 470     470    
Foreign currency translation adjustment 7,739     7,229   510
Cash contributions to majority-owned subsidiaries 0   (290)     290
Net (loss) income (273,911)       (223,355) (50,556)
Ending balance (in shares) at Jun. 30, 2025   682,229,832        
Ending balance at Jun. 30, 2025 4,815,906 $ 0 4,644,085 17,137 (315,588) 470,272
Beginning balance (in shares) at Mar. 31, 2025   695,938,323        
Beginning balance at Mar. 31, 2025 5,187,198 $ 0 4,562,107 9,438 116,060 499,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized (losses) gains on available-for-sale securities 3,051          
Amounts reclassified from accumulated other comprehensive income (loss) 0          
Net (loss) income (439,950)          
Ending balance (in shares) at Sep. 30, 2025   689,697,370        
Ending balance at Sep. 30, 2025 4,805,458 $ 0 4,771,880 19,558 (429,107) 443,127
Beginning balance (in shares) at Jun. 30, 2025   682,229,832        
Beginning balance at Jun. 30, 2025 4,815,906 $ 0 4,644,085 17,137 (315,588) 470,272
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   7,386,746        
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments 45,569   45,569      
Exercise and vesting of subsidiary share awards 25,109   14,110     10,999
Issuance of the Company’s common shares under employee stock purchase plan (in shares)   80,792        
Issuance of the Company’s common shares under employee stock purchase plan 774   774      
Share-based compensation 81,821   67,845     13,976
Unrealized (losses) gains on available-for-sale securities 2,581     2,581    
Foreign currency translation adjustment (263)     (160)   (103)
Cash contributions to majority-owned subsidiaries 0   (503)     503
Amounts reclassified from accumulated other comprehensive income (loss) 0          
Net (loss) income (166,039)       (113,519) (52,520)
Ending balance (in shares) at Sep. 30, 2025   689,697,370        
Ending balance at Sep. 30, 2025 $ 4,805,458 $ 0 4,771,880 19,558 (429,107) 443,127
Beginning balance (in shares) at Mar. 31, 2026 720,352,386 720,352,386        
Beginning balance at Mar. 31, 2026 $ 5,292,412 $ 0 5,024,826 4,358 (501,814) 765,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   9,208,139        
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments 24,596   24,596      
Exercise and vesting of subsidiary share awards 23,634   13,470     10,164
Issuance of subsidiary shares to the Company and cash contributions to majority-owned subsidiaries 0   (1,265)     1,265
Repurchase of the Company's common shares (in shares)   (6,892,463)        
Repurchase of the Company’s common shares (208,703)       (208,703)  
Issuance of the Company’s common shares under employee stock purchase plan 635   635      
Share-based compensation 83,342   68,664     14,678
Unrealized (losses) gains on available-for-sale securities (2,987)     (2,987)    
Foreign currency translation adjustment (454)     (670)   216
Net (loss) income (290,606)       (189,837) (100,769)
Ending balance (in shares) at Jun. 30, 2026   722,668,062        
Ending balance at Jun. 30, 2026 $ 4,921,869 $ 0 5,130,926 701 (900,354) 690,596
Beginning balance (in shares) at Mar. 31, 2026 720,352,386 720,352,386        
Beginning balance at Mar. 31, 2026 $ 5,292,412 $ 0 5,024,826 4,358 (501,814) 765,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized (losses) gains on available-for-sale securities (12,738)          
Amounts reclassified from accumulated other comprehensive income (loss) 10          
Net (loss) income $ (427,817)          
Ending balance (in shares) at Sep. 30, 2026 723,687,406 723,687,406        
Ending balance at Sep. 30, 2026 $ 4,595,720 $ 0 5,193,719 (8,931) (1,164,473) 575,405
Beginning balance (in shares) at Jun. 30, 2026   722,668,062        
Beginning balance at Jun. 30, 2026 4,921,869 $ 0 5,130,926 701 (900,354) 690,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   3,452,317        
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (5,595)   (5,595)      
Exercise and vesting of subsidiary share awards 6,366   3,719     2,647
Repurchase of the Company's common shares (in shares)   (2,467,035)        
Repurchase of the Company’s common shares (72,500)       (72,500)  
Issuance of the Company’s common shares under employee stock purchase plan (in shares)   34,062        
Share-based compensation 79,297   65,672     13,625
Unrealized (losses) gains on available-for-sale securities (9,751)     (9,751)    
Foreign currency translation adjustment (198)     109   (307)
Cash contributions to majority-owned subsidiaries 0   (1,003)     1,003
Distribution by subsidiary (186,567)         (186,567)
Amounts reclassified from accumulated other comprehensive income (loss) 10     10    
Net (loss) income $ (137,211)       (191,619) 54,408
Ending balance (in shares) at Sep. 30, 2026 723,687,406 723,687,406        
Ending balance at Sep. 30, 2026 $ 4,595,720 $ 0 $ 5,193,719 $ (8,931) $ (1,164,473) $ 575,405